semaglutide compound fda approved Hims & Hers stock falls 25% as curtails compounded GLP-1s The FDA's Decision to Ban
Description
( Epub 2016/03/20 )

F., Nadzirin, N., Velankar, S

International Journal of Obesity and Related Metabolic Disorders

We will keep watching the clinical trial landscape as more GLP-1 and GLP-1 like drugs are developed
